BriaCell Therapeutics Corp. (BCTX) stock
BCTXNasdaqPharmaceutical PreparationsFiscal year ends July 31Also trades as BCTXL, BCTXZ
$3.51+0.21 (+6.36%)
Close on Nov 17, 2026Market cap $30.65MP/E –Yield –
BriaCell Therapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
BriaCell Therapeutics's market cap was $31.26M on Nov 11, 2026, against $5.10M a year earlier. Over the last 5 years it ranged from $4.89M to $151.09M, with a median of $31.63M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $31.26M | +70.5% |
| 2025 | Nov 28, 2025 | $18.33M | -10.3% |
| 2024 | Dec 31, 2024 | $20.44M | -78.1% |
| 2023 | Dec 29, 2023 | $93.49M | +37.1% |
| 2022 | Dec 30, 2022 | $68.19M | -46.4% |
| 2021 | Dec 31, 2021 | $127.14M | +4147.3% |
| 2020 | Dec 31, 2020 | $2.99M | – |
See a number that looks wrong?